Cardiovascular and Circulatory System Acute Coronary Syndromes

Table of Contents

RECENT HIGHLIGHTS AND CHANGES
--Recent Highlights and Changes
UPCOMING PATENT EXPIRES BY THERAPY AREA
Acute Coronary Syndromes Pipeline Overview
--% of Projects (By Phase of Development)
--No. of Projects by Phase of Development
--Marketed Products Vs. Pipeline Products
Company Overview - Pipeline Projects
--Company Overview - Pipeline Projects

--Top Companies in late stage Acute Coronary Syndromes Projects
--Bayer Schering Pharma AG
--Archemix Corp.
--CSL Behring
--erly ZLB Behring)
--Bristol-Myers Squibb Company
--DAIICHI SANKYO COMPANY, LIMITED
--CSL Limited
--GlaxoSmithKline plc
--Eli Lilly & Co
--Medicure Inc
--Kissei Pharmaceutical Co., Ltd.
--Millennium Pharmaceuticals Inc
--Merck & Co Inc
--Pfizer Inc
--Momenta Pharmaceuticals Inc
--Schering-Plough Corp
--Sanofi-Aventis
--Vertex Pharmaceuticals Inc
--The Medicines Company
--Viron Therapeutics Inc
--VIA Pharmaceuticals, Inc.

--Top Companies in early stage Acute Coronary Syndromes Projects
--BioCryst Pharmaceuticals Inc
--Cardium Therapeutics Inc
--Regado Biosciences, Inc.
--Trigen Holdings AG

Pipeline Revenue
--Pipeline Revenue
Full Pipeline View
--Pre Clinical Pipeline View
--Phase I Pipeline View
--Phase II Pipeline View
--Phase III Pipeline View
--Pending Approval Pipeline View
--On the Market Pipeline View
--Discovery/Development Pipeline View